Cargando…
SB203580, a p38MAPK inhibitor, attenuates olfactory dysfunction by inhibiting OSN apoptosis in AR mice (activation and involvement of the p38 mitogen‐activated protein kinase in olfactory sensory neuronal apoptosis of OVA‐induced allergic rhinitis)
OBJECTIVE: This study aimed to investigate the effect of the p38 mitogen‐activated protein kinase (p38MAPK) signaling pathway on olfactory mucosa function and apoptosis of olfactory sensory neurons (OSNs) in an allergic rhinitis (AR) mouse model. METHOD: Fifty‐five BALB/c mice were used to establish...
Autores principales: | Gao, Xian, Li, Na, Zhang, Jisheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6577615/ https://www.ncbi.nlm.nih.gov/pubmed/31041850 http://dx.doi.org/10.1002/brb3.1295 |
Ejemplares similares
-
In vitro modeling of COPD inflammation and limitation of p38 inhibitor – SB203580
por: Meng, Aihong, et al.
Publicado: (2016) -
The p38 MAPK inhibitor SB203580 differentially modulates LPS-induced interleukin 6 expression in macrophages
por: Shi, Qinghai, et al.
Publicado: (2015) -
SB203580—A Potent p38 MAPK Inhibitor Reduces the Profibrotic Bronchial Fibroblasts Transition Associated with Asthma
por: Paw, Milena, et al.
Publicado: (2021) -
SB203580 Modulates p38 MAPK Signaling and Dengue Virus-Induced Liver Injury by Reducing MAPKAPK2, HSP27, and ATF2 Phosphorylation
por: Sreekanth, Gopinathan Pillai, et al.
Publicado: (2016) -
The p38 MAPK Inhibitor SB203580 Abrogates Tumor Necrosis Factor-Induced Proliferative Expansion of Mouse CD4(+)Foxp3(+) Regulatory T Cells
por: He, Tianzhen, et al.
Publicado: (2018)